{"id":61862,"date":"2025-09-13T04:02:26","date_gmt":"2025-09-13T02:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/"},"modified":"2025-09-13T04:02:26","modified_gmt":"2025-09-13T02:02:26","slug":"a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/","title":{"rendered":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership"},"content":{"rendered":"<div>\n<p>PHOENIX&#8211;(BUSINESS WIRE)&#8211;Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/5\/LOGO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/5\/LOGO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/21\/LOGO.jpg\"><\/a><\/p>\n<p>\nFABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation of scientific validation to bring the technology into a commercially viable, pharmacy-ready solution for the first time in the United States.<\/p>\n<p>\n\u201cCompounding pharmacies have been eager for meaningful innovation that improves efficiency, enhances compliance, and expands their ability to personalize care for patients,\u201d said Dan Siddall, Founder of Pete Pharma. \u201cBy combining FABRX\u2019s proven scientific expertise with Pete Pharma\u2019s commercialization strategy, we\u2019re making pharmaceutical 3D printing not just possible, but practical and scalable across the U.S. market.\u201d<\/p>\n<p>\nThe introduction of pharmaceutical 3D printing offers compounding pharmacies the ability to:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nImprove workflow efficiency by automating labor-intensive processes<\/li>\n<li>\nEnable greater personalization of medications, particularly in areas such as pediatrics, lifestyle therapeutics, HRT, and metabolic care<\/li>\n<li>\nEnhance quality and compliance through in-line quality control and digital traceability<\/li>\n<\/ul>\n<p>\nIn addition to bringing FABRX\u2019s validated technology to the U.S., Pete Pharma will launch the platform through a first-of-its-kind business model that transforms how pharmacies access innovation. This model is designed to be:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<span class=\"bwuline\">Pharmacy-First<\/span>: the first-of-its-kind model is built around the needs of the pharmacies, ensuring that success is not measured just by the delivery of technology, but by the value and outcomes created through the compounded products themselves<\/li>\n<li>\n<span class=\"bwuline\">Scalable<\/span>: accessible to independent pharmacies nationwide<\/li>\n<li>\n<span class=\"bwuline\">Efficient<\/span>: reducing the burden of labor and consumable waste<\/li>\n<li>\n<span class=\"bwuline\">Forward-looking<\/span>: addressing regulatory requirements head-on while reshaping the conventional distribution model in compounding<\/li>\n<\/ul>\n<p>\n\u201cThis is more than a technology launch; it\u2019s the beginning of a new era for compounding pharmacies,\u201d added Dan Siddall. \u201cWe\u2019re building a model that makes advanced pharmaceutical technology available in a way that works for the realities of the compounding industry.\u201d<\/p>\n<p>\nThe partnership between Pete Pharma and FABRX positions both organizations to set the standard for innovation in compounding, creating a future where pharmacies can operate more efficiently while delivering better, more effective therapies for patients.<\/p>\n<p>\n<b>About Pete Pharma<\/b><\/p>\n<p>\nPete Pharma is a U.S.-based innovator focused on transforming the compounding industry through advanced technologies, proprietary base formulations, and commercialization strategies. With a pharmacy-first approach, Pete Pharma partners directly with compounding pharmacies to deliver scalable solutions that improve efficiency, compliance, and patient outcomes.<\/p>\n<p>\n<b>About FABRX<\/b><\/p>\n<p>\nFABRX, founded in 2014, is a global leader in pharmaceutical 3D printing technology. Spun out of University College London, FABRX has spent over a decade pioneering research and clinical applications of 3D printing in hospitals, universities, and research centers worldwide. Its M3DIMAKER platform is the first pharmaceutical 3D printer designed specifically for personalized medicines.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nDan Siddall<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#108;&#x74;&#x6f;&#x3a;Da&#110;&#64;&#x70;&#x65;&#x74;&#x65;ph&#97;&#114;&#x6d;&#x61;&#x2e;&#x63;o&#109;\" rel=\"nofollow\" shape=\"rect\">&#x44;a&#x6e;&#64;&#x70;&#101;t&#x65;p&#x68;&#97;&#x72;&#109;a&#x2e;&#99;&#x6f;&#109;<\/a><br \/>(720) 891-3770<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHOENIX&#8211;(BUSINESS WIRE)&#8211;Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market. FABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61862","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PHOENIX&#8211;(BUSINESS WIRE)&#8211;Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market. FABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-13T02:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership\",\"datePublished\":\"2025-09-13T02:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/\"},\"wordCount\":486,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250912350487\\\/en\\\/2579203\\\/22\\\/LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/\",\"name\":\"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250912350487\\\/en\\\/2579203\\\/22\\\/LOGO.jpg\",\"datePublished\":\"2025-09-13T02:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250912350487\\\/en\\\/2579203\\\/22\\\/LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250912350487\\\/en\\\/2579203\\\/22\\\/LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/","og_locale":"en_US","og_type":"article","og_title":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend","og_description":"PHOENIX&#8211;(BUSINESS WIRE)&#8211;Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market. FABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-13T02:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership","datePublished":"2025-09-13T02:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/"},"wordCount":486,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/","url":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/","name":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg","datePublished":"2025-09-13T02:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250912350487\/en\/2579203\/22\/LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/a-pharmacy-first-approach-to-innovation-pete-pharma-and-fabrx-announce-partnership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61862"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61862\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}